Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04998357 · ClinicalTrials.gov registry record · NA
Autologous Mitochondrial Transplant for Cerebral Ischemia
A NA study of Cerebral Ischemia, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04998357: Recruiting NA study of Cerebral Ischemia, sponsored by University of Washington.
NCT04998357 is a NA study of Cerebral Ischemia that is actively recruiting participants, run by University of Washington. The registered enrollment target is 20 participants, below the 15,140-participant average among 4 other Cerebral Ischemia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04998357, a NA study of Cerebral Ischemia, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
Primary Outcome
Cerebral angiography is performed and reviewed in real-time throughout the standard of care reperfusion treatment, including before and after microcatheter infusion of mitochondria.
Conditions Studied
Interventions
- OTHER Endovascular autologous mitochondrial transplantation
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2026-10-29 |
| Phase | NA |
What NCT04998357 shows while recruiting
NCT04998357 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 15,140-participant average among 4 other Cerebral Ischemia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Cerebral Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Endovascular autologous mitochondrial transplantation is the first listed.
NCT04998357 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04998357 about?
NCT04998357 is a clinical study titled "Autologous Mitochondrial Transplant for Cerebral Ischemia". The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
What is the current status of trial NCT04998357?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-04-29. Estimated completion is 2026-10-29.
What conditions does trial NCT04998357 study?
This clinical trial studies the following conditions: Cerebral Ischemia.
What interventions are being tested in trial NCT04998357?
The interventions under investigation include: Endovascular autologous mitochondrial transplantation (OTHER).
Who is sponsoring clinical trial NCT04998357?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04998357 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI